These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34117362)

  • 21. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetically modulated FOXM1 suppresses dendritic cell maturation in pancreatic cancer and colon cancer.
    Zhou Z; Chen H; Xie R; Wang H; Li S; Xu Q; Xu N; Cheng Q; Qian Y; Huang R; Shao Z; Xiang M
    Mol Oncol; 2019 Apr; 13(4):873-893. PubMed ID: 30628173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dickkopf-1 is involved in invasive growth of esophageal cancer cells.
    Li S; Qin X; Liu B; Sun L; Zhang X; Li Z; Shan B; You J; Zhou Q
    J Mol Histol; 2011 Dec; 42(6):491-8. PubMed ID: 21909757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4.
    Kajiwara C; Fumoto K; Kimura H; Nojima S; Asano K; Odagiri K; Yamasaki M; Hikita H; Takehara T; Doki Y; Morii E; Kikuchi A
    Cancer Res; 2018 Nov; 78(21):6107-6120. PubMed ID: 30181180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GFI1 promotes the proliferation and migration of esophageal squamous cell carcinoma cells through the inhibition of SOCS1 expression.
    Huang Y; Ruan R; Fang Y; Wu K; Yao L; Zhang R; He W
    Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma.
    Igbinigie E; Guo F; Jiang SW; Kelley C; Li J
    Clin Chim Acta; 2019 Jan; 488():226-234. PubMed ID: 30452897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broussoflavonol B from
    Jeong JH; Ryu JH
    Molecules; 2020 May; 25(10):. PubMed ID: 32429421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DKK1-SE recruits AP1 to activate the target gene DKK1 thereby promoting pancreatic cancer progression.
    Shao L; Yu H; Wang M; Chen L; Ji B; Wu T; Teng X; Su M; Han X; Shi W; Hu X; Wang Z; He H; Han G; Zhang Y; Wu Q
    Cell Death Dis; 2024 Aug; 15(8):566. PubMed ID: 39107271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.
    Hui MK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
    World J Surg; 2012 Jan; 36(1):90-7. PubMed ID: 21976009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
    Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
    Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel signalling pathway and may represent a molecular target for cancer therapy.
    Kikuchi A; Fumoto K; Kimura H
    Br J Pharmacol; 2017 Dec; 174(24):4651-4665. PubMed ID: 28514532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
    Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y
    Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newly developed humanized anti-CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1-CKAP4 signaling.
    Sada R; Yamamoto H; Matsumoto S; Harada A; Kikuchi A
    Cancer Sci; 2024 Oct; 115(10):3358-3369. PubMed ID: 39118263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological and prognostic significance of FOXM1 expression in esophageal squamous cell carcinoma.
    Takata A; Takiguchi S; Okada K; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Mori M; Doki Y
    Anticancer Res; 2014 May; 34(5):2427-32. PubMed ID: 24778055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXM 1 induces Vasculogenic mimicry in esophageal cancer through β-catenin /Tcf4 signaling.
    Cheng L; Wang Q; Tao X; Qin Y; Wu Q; Zheng D; Chai D; Zhang Y; Lu D; Ci H; Wang Z; Ma J; Wang D; Cheng Z; Wu S; Tao Y
    Diagn Pathol; 2020 Feb; 15(1):14. PubMed ID: 32035486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas.
    Yamabuki T; Takano A; Hayama S; Ishikawa N; Kato T; Miyamoto M; Ito T; Ito H; Miyagi Y; Nakayama H; Fujita M; Hosokawa M; Tsuchiya E; Kohno N; Kondo S; Nakamura Y; Daigo Y
    Cancer Res; 2007 Mar; 67(6):2517-25. PubMed ID: 17363569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
    Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
    Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
    Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
    J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.